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Roles of the mitochondrial Na+-Ca2+ 
exchanger, NCLX, in B lymphocyte 
chemotaxis
Bongju Kim1,*,†, Ayako Takeuchi2,*, Masaki Hikida1 & Satoshi Matsuoka1,2
Lymphocyte chemotaxis plays important roles in immunological reactions, although the mechanism 
of its regulation is still unclear. We found that the cytosolic Na+-dependent mitochondrial Ca2+ efflux 
transporter, NCLX, regulates B lymphocyte chemotaxis. Inhibiting or silencing NCLX in A20 and DT40 
B lymphocytes markedly increased random migration and suppressed the chemotactic response to 
CXCL12. In contrast to control cells, cytosolic Ca2+ was higher and was not increased further by CXCL12 
in NCLX-knockdown A20 B lymphocytes. Chelating intracellular Ca2+ with BAPTA-AM disturbed 
CXCL12-induced chemotaxis, suggesting that modulation of cytosolic Ca2+ via NCLX, and thereby 
Rac1 activation and F-actin polymerization, is essential for B lymphocyte motility and chemotaxis. 
Mitochondrial polarization, which is necessary for directional movement, was unaltered in NCLX-
knockdown cells, although CXCL12 application failed to induce enhancement of mitochondrial 
polarization, in contrast to control cells. Mouse spleen B lymphocytes were similar to the cell lines, 
in that pharmacological inhibition of NCLX by CGP-37157 diminished CXCL12-induced chemotaxis. 
Unexpectedly, spleen T lymphocyte chemotaxis was unaffected by CGP-37157 treatment, indicating 
that NCLX-mediated regulation of chemotaxis is B lymphocyte-specific, and mitochondria-endoplasmic 
reticulum Ca2+ dynamics are more important in B lymphocytes than in T lymphocytes. We conclude that 
NCLX is pivotal for B lymphocyte motility and chemotaxis.
Migration of lymphocytes is one of the fundamental processes of the immune response. In the case of B lym-
phocytes, circulating naive lymphocytes enter lymph nodes through high endothelial venules, migrate to the B 
cell area where chemoattractants such as CXCL12 and CXCL13 are highly expressed, and are then activated and 
differentiated into plasma cells1,2. This directional movement of the cell toward chemoattractants, i.e. chemotaxis, 
is triggered by an interaction between chemokines and their receptors. The interaction of a chemokine with its 
receptor (e.g. CXCL12 with CXCR4, and CXCL13 with CXCR5), as well as the subsequent signal transduction 
pathways, such as MAPKs, PI3K, and NF-κB, have been extensively studied using a variety of cell types, including 
lymphocytes (see reviews3–6). However, detailed mechanisms underlying lymphocyte chemotaxis have not yet 
been clarified.
Ca2+ is an important second messenger which regulates chemotaxis. It is well known that various cellular 
processes involved in cell motility are Ca2+-sensitive. For example, a rise or oscillation in cytosolic Ca2+ acti-
vates cytoskeletal remodelling through the small GTPase Rac1, thereby modulating migration of T lymphocytes, 
tumour mast cells and podocytes7–9. The Ca2+ mobilization is mediated by Ca2+ influx via plasma membrane 
Ca2+ channels and/or Ca2+ release from intracellular stores such as the endoplasmic reticulum (ER). Various Ca2+ 
carriers localized at the plasma membrane and in the ER, such as transient receptor potential channels (TRPs), 
the store-operated Ca2+ entry system (stim1/orai1), ER Ca2+ release channels (inositol trisphosphate receptors), 
and the ER Ca2+ pump (SERCA), have been implicated in the regulation of the migration of various kinds of 
cells10–14. As for T lymphocytes, several lines of evidence suggest the involvement of TRPs and stim1/orai1 in Ca2+ 
mobilization-mediated migration, though little information is available on B lymphocyte migration11,12.
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Besides the ER, mitochondria provide an important Ca2+ store inside the cell. Mitochondrial Ca2+ dynam-
ics is determined by influx via the Ca2+ uniporter and efflux via the Na+-Ca2+ exchanger and/or the H+-Ca2+ 
exchanger15,16. In 2013, MCU, which encodes the mitochondrial Ca2+ uniporter, and MICU, which is a regulator 
of MCU, were reported to be involved in the migration of human endothelial cells and zebrafish blastomeres17,18. 
MCU-mediated alterations in cytosolic Ca2+ dynamics and/or the production of mitochondrial reactive oxygen 
species were implicated in migration, though the exact mechanisms are still unresolved. Moreover, little is known 
as to whether, and if so, how mitochondrial Ca2+ efflux transporters participate in lymphocyte chemotaxis.
We recently demonstrated that NCLX, a gene responsible for the mitochondrial Na+-Ca2+ exchanger19, acts 
to provide Ca2+ to the endoplasmic/sarcoplasmic reticulum (ER/SR), and that NCLX-mediated Ca2+ recycling 
between mitochondria and the ER/SR modulates various cellular functions20–22. In B lymphocytes, NCLX is piv-
otal in maintaining cellular Ca2+ responses to antigens20,21. Considering that cytosolic Ca2+ dynamics participate 
in the migration of various kinds of cells, we hypothesized that NCLX may participate in lymphocyte migration 
and/or chemotaxis. In the present study, we studied the roles of NCLX in lymphocyte chemotaxis. We found that 
NCLX reduction/inhibition markedly suppressed chemotaxis while increasing the random migration of B lym-
phocytes. In addition, we found that the contributions of NCLX to motility were observed only in B lymphocytes 
and not in T lymphocytes.
Results
Facilitation of random migration and inhibition of chemotaxis by NCLX silencing in B lympho-
cytes. We first investigated whether pharmacological intervention of mitochondrial Ca2+ carriers affected 
the chemotaxis of A20 B lymphocytes. A standard Transwell assay was employed to measure chemotaxis. When 
CXCL12 was present in the bottom chamber, there was a significant increase in the movement of A20 B lym-
phocytes toward the bottom chamber; that is, CXCL12 induced chemotaxis of A20 B lymphocytes (Fig. 1). 
Perturbation of mitochondrial Na+-Ca2+ exchange by CGP-37157 (IC50 = 0.36 μM)23 dose-dependently decreased 
the extent of chemotaxis, while it did not affect the basal cell movement up to 2 μM. A high concentration of CGP-
37157 (20 μM) significantly decreased both chemotaxis and basal cell movement. On the other hand, inhibition of 
the mitochondrial Ca2+ uniporter by Ru360 (IC50 = 0.2–2 nM)24,25 did not affect the extent of chemotaxis or basal 
cell movement, even at 50 μM (Fig. 1).
We then tested whether the mitochondrial Na+-Ca2+ exchanger-mediated modulation of chemotaxis occurred 
in another B lymphocyte cell line, DT40. In heterozygous NCLX knockout DT40 B lymphocytes (NCLX+/−), 
in which NCLX protein expression was negligible20, CXCL12-induced chemotaxis was significantly suppressed 
(Supplementary Fig. S1), suggesting that the mitochondrial Na+-Ca2+ exchanger is a key determinant for the 
chemotaxis of B lymphocytes.
To evaluate individual cell motility, we next performed live-cell imaging using A20 B lymphocytes. Silencing 
of NCLX using siRNA has previously been shown to reduce NCLX mRNA expression20. We reconfirmed this 
in the present study by performing quantitative PCR, which resulted in the reduction of NCLX mRNA expres-
sion to 45.4 ± 10.8% (N = 3). Single-cell tracking revealed that control siRNA-transfected A20 B lymphocytes 
(siControl) moved randomly in the absence of CXCL12. Interestingly, under this condition, NCLX knockdown 
(siNCLX) cells showed higher velocity and mean displacement (Fig. 2a,b,d), indicating that NCLX knockdown 
facilitated random migration. In siControl cells, a CXCL12 gradient increased motility and induced directional 
movement toward CXCL12; chemotaxis clearly occurred (Fig. 2a–d). On the contrary, in the siNCLX cells, the 
CXCL12 gradient did not further increase motility or induce directional movement toward CXCL12 (Fig. 2a–d); 
this is comparable to the results of the Transwell assays. Similar results were obtained using 2 μM CGP-37157 to 
block mitochondrial Na+-Ca2+ exchange in A20 B lymphocytes (Supplementary Fig. S2a–c). In addition, ran-
dom cell movement and migration velocity were higher in NCLX+/− DT40 B lymphocytes compared with that 
in wild-type (WT) cells (Supplementary Fig. S2d,e), in accord with the facilitation of migration by the reduction 
Figure 1. Suppression of chemotaxis by mitochondrial Na+-Ca2+ exchange inhibition in A20 B 
lymphocytes. Effects of a mitochondrial Na+-Ca2+ exchange inhibitor (CGP-37157) and a mitochondrial 
Ca2+ uniporter inhibitor (Ru360) on CXCL12-induced chemotaxis in a Transwell assay. Cells were pretreated 
with various concentrations of drugs as indicated (μM) and then were applied to the upper chamber. CXCL12 
(100 ng/ml) was applied to the lower chamber in the presence or absence of the drug. N = 4. Data are expressed 
as mean ± SEM. **P < 0.01, *P < 0.05, n.s. not significant.
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or inhibition of NCLX in A20 B lymphocytes (Fig. 2a,b,d, Supplementary Fig. S2). Bath application of CXCL12 
did not further augment the random cell movement and the migration velocity of NCLX+/− DT40 B lympho-
cytes (Supplementary Fig. S2d,e); this is comparable to the results obtained from A20 B lymphocytes (Fig. 2, 
Supplementary Fig. S2). We confirmed that the expression level of the CXCL12 receptor, CXCR4, was unaffected 
by NCLX knockdown (Supplementary Fig. S3), suggesting that NCLX reduction/inhibition-mediated alterations 
of motility were not due to altered CXCL12/CXCR4 interaction. Thus, the silencing of NCLX facilitated random 
migration while inhibiting chemotaxis in B lymphocytes.
Association of altered cytosolic Ca2+ with NCLX-mediated modulation of cell motility. 
Considering that various cellular processes involved in motility are Ca2+ sensitive10–14, and that NCLX is pivotal 
for cytosolic Ca2+ signalling during B cell receptor activation20, we hypothesized that NCLX participates in motil-
ity via modulation of cytosolic Ca2+. In siNCLX cells, cytosolic Ca2+ concentration was higher than that in siCon-
trol cells in the absence of CXCL12 (Fig. 3a,b). In siControl cells, CXCL12 treatment significantly increased the 
cytosolic Ca2+. However, it did not further increase the cytosolic Ca2+ in siNCLX cells (Fig. 3a,b). Essentially the 
same results were obtained by blocking mitochondrial Na+-Ca2+ exchange using CGP-37157 at 2 and 20 μM; i.e. 
treatment with CGP-37157 increased cytosolic Ca2+ in the absence of CXCL12, and CXCL12 application did not 
further increase but rather decreased cytosolic Ca2+ when the cells were treated with CGP-37157 (Supplementary 
Fig. S4). These results well correspond to the data showing that siNCLX cells had higher motility than siControl 
cells in the absence of CXCL12, and that CXCL12 application induced chemotaxis in siControl cells, but not in 
siNCLX cells (Fig. 2a,b,d). The importance of cytosolic Ca2+ in cell motility was confirmed by chelating cytosolic 
Ca2+ during a live-cell chemotaxis assay. Treatment of the cells with 25 μM BAPTA-AM significantly diminished 
motility, as revealed by decreased mean displacement as well as decreased velocity (Fig. 3c–e). The above findings 
suggested that altered cytosolic Ca2+ was associated with NCLX-mediated modulation of cell motility.
Facilitation of F-actin polymerization and Rac1 localization in NCLX knockdown cells. In 
order to elucidate how cytosolic Ca2+ alteration modulates cell motility in NCLX-silenced cells, we next focused 
on actin rearrangement and localization of Rac1, a member of a small GTPase family, because both had been 
reported to be Ca2+-sensitive and to be key factors determining cell migration and chemotaxis8,9,26–31. The dis-
tribution of F-actin was evaluated by staining the cells with fluorescently-labelled phalloidin. In siControl cells, 
F-actin was confined to a small area in the absence of CXCL12. On the other hand, siNCLX cells had a less con-
fined F-actin distribution than siControl cells. After bath application of CXCL12, the F-actin region was signifi-
cantly expanded in siControl cells but was unaltered in siNCLX cells (Fig. 4). Localization of Rac1 was examined 
by immunocytochemistry. As clearly shown in Supplementary Fig. S5, Rac1 was more diffusely distributed in 
siNCLX cells than in siControl cells in the absence of CXCL12. After bath application of CXCL12, the Rac1 region 
expanded in siControl cells but contracted in siNCLX cells. The effects of NCLX knockdown and/or CXCL12 
application on F-actin and Rac1 localization were quite similar in pattern to the effects on cytosolic Ca2+ and cell 
motility. Accordingly, it was suggested that the NCLX knockdown-mediated increase of cytosolic Ca2+ facilitated 
F-actin formation and Rac1 localization, resulting in the augmentation of random cell migration.
Association of CXCL12-induced polarization of mitochondria with directional cell movement of 
A20 B lymphocytes. At this point, we were faced with the question of why directional movement towards 
Figure 2. Facilitation of random migration and suppression of chemotaxis by NCLX knockdown in A20 B 
lymphocytes. Effects of NCLX knockdown on CXCL12-induced chemotaxis in a real-time chemotaxis assay. 
N = 4–5. (a) Representative data for the trajectory of each cell movement. CXCL12 (100 ng/ml) was applied to 
the left side of the reservoir. (b) Velocity of cells. (c) Percentage of cells which moved toward CXCL12. (d) Mean 
displacement of cells. Data are expressed as mean ± SEM. siControl, control siRNA transfected cells. siNCLX, 
NCLX siRNA transfected cells. **P < 0.01, *P < 0.05, n.s. not significant.
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CXCL12, i.e. chemotaxis, did not occur in siNCLX cells, in spite of the increased random cell migration. In seek-
ing the answer, we analysed mitochondrial polarization (Fig. 5), which had been reported to be important for 
directional cell movement in a variety of cell types32–35. In siControl cells, mitochondria stained with MitoTracker 
Orange were distributed evenly within the cell, and CXCL12 application induced mitochondrial accumulation in 
one part of the cell. In siNCLX cells, the mitochondrial distribution was similar to siControl cells in the absence 
of CXCL12, despite the alteration of F-actin formation and Rac1 localization (Fig. 4 and Supplementary Fig. S5). 
CXCL12 application failed to induce mitochondrial polarization in the siNCLX cells. Thus, the CXCL12-induced 
mitochondrial polarization may be associated with the directional movement of the cell and chemotaxis but 
not with velocity and extent of movement. Similar results were obtained using NCLX+/− DT40 B lymphocytes 
(Supplementary Fig. S6).
Figure 3. Importance of cytosolic Ca2+ for the motility of A20 B lymphocytes. (a,b) Effects of NCLX 
knockdown on cytosolic Ca2+ in the absence and presence of 100 ng/ml CXCL12, evaluated by staining the  
cells with Fura 2-AM (5 μM). (a) Representative data 2 hrs after the CXCL12 application. (b) Summary. N = 6. 
(c–e) Effects of chelating cytosolic Ca2+ on CXCL12-induced chemotaxis. (c) Representative data for cell 
trajectory. CXCL12 (100 ng/ml) was applied to the left side of the reservoir, and chemotaxis was observed in 
the absence (left) or presence (right) of the Ca2+ chelator BAPTA-AM (25 μM) in both sides of the reservoir. 
(d) Mean displacement of cells. (e) Velocity of cells. N = 4. Data are expressed as mean ± SEM. **P < 0.01, 
*P < 0.05, n.s. not significant.
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B lymphocyte specificity of NCLX-mediated modulation of chemotaxis. Finally, we examined 
whether the above findings were applicable to native B lymphocytes. We performed live-cell imaging of isolated 
mouse spleen B lymphocytes and evaluated chemotaxis toward CXCL12 (Fig. 6a–c), in comparison with T lym-
phocytes (Fig. 6d–f). In both B and T lymphocytes isolated from mouse spleen, the CXCL12 gradient induced 
chemotaxis (Fig. 6a,b,d,e). Blocking NCLX with 2 μM CGP-37157 significantly suppressed B lymphocyte chemo-
taxis and motility in the presence of CXCL12 (Fig. 6a–c). These results suggested that NCLX had important roles 
in the chemotaxis of mouse spleen B lymphocytes, similar to B lymphocyte cell lines. In contrast, CGP-37157 did 
not affect the chemotaxis or motility of T lymphocytes (Fig. 6d–f), indicating that the contribution of NCLX to 
chemotaxis was specific to B lymphocytes.
NCLX-mediated mitochondria-ER Ca2+ recycling is pivotal for the cytosolic Ca2+ response to B cell 
receptor stimulation20 and NCLX-mediated regulation of cytosolic Ca2+ is associated with the motility of 
B lymphocytes (Fig. 3, Supplementary Fig. S4). These facts prompted us to compare B and T lymphocytes in 
terms of their expression of Ca2+ carriers and a Ca2+ binding protein that determine cytosolic Ca2+ dynam-
ics (Fig. 7a). Interestingly, the mRNA levels of factors involved in mitochondria-ER Ca2+ dynamics, such as 
Figure 4. Augmentation of F-actin polymerization in NCLX knockdown A20 B lymphocytes. Effects of 
NCLX knockdown on F-actin polymerization in the absence and presence of 100 ng/ml CXCL12, evaluated by 
using fluorescently labelled phalloidin (green). Nuclei were stained with DAPI (blue). (a) Representative data. 
(b) Summary. N = 3. Data are expressed as mean ± SEM. *P < 0.05, n.s. not significant.
Figure 5. Attenuation of CXCL12-induced mitochondrial polarization in NCLX knockdown A20 B 
lymphocytes. Effects of NCLX knockdown on mitochondrial polarization in the absence or presence of  
100 ng/ml CXCL12, evaluated by staining the cells with a mitochondria specific dye (MitoTracker Orange, red). 
(a) Representative data. (b) Summary. N = 15. Data are expressed as mean ± SEM. **P < 0.01, *P < 0.05, n.s. 
not significant.
www.nature.com/scientificreports/
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NCLX, the possible mitochondrial H+/Ca2+ exchanger Letm1, the ER Ca2+ pump SERCA3, three ER inositol 
trisphosphate receptor Ca2+ release channels (IP3Rs 1–3), and the ER Ca2+ binding protein calreticulin, were 
significantly higher in B lymphocytes than in T lymphocytes. It should be noted that the expression levels of 
mitochondrial adenine nucleotide translocator 2 (ANT2) and ATP synthase subunit ATP5b were comparable 
between B and T lymphocytes, suggesting that the cellular content of mitochondria is similar in the two cell 
types. In addition, the expression level of orai1, which mediates Ca2+ influx across the plasma membrane in 
response to ER Ca2+ depletion, was also higher in B lymphocytes than in T lymphocytes. On the other hand, 
the expression levels of other Ca2+ carriers in plasma membrane, such as the Na+-Ca2+ exchangers NCX1–3 
and the Ca2+ pump PMCA1, were comparable between B and T lymphocytes. These results suggest that the 
contribution of organelle Ca2+ dynamics to cytosolic Ca2+ was larger in B lymphocytes than in T lympho-
cytes. In fact, the cytosolic Ca2+ response to antigen receptor stimulation was sensitive to the mitochondrial 
Na+-Ca2+ exchange blocker CGP-37157 in B lymphocytes but not in T lymphocytes (Fig. 7b,c). The larger 
contribution of organelle Ca2+ dynamics may be related to the larger contribution of NCLX to chemotaxis in 
B lymphocytes than in T lymphocytes.
Figure 6. NCLX-mediated modulation of chemotaxis in spleen B lymphocytes. Effects of the mitochondrial 
Na+-Ca2+ exchange inhibitor CGP-37157 on CXCL12-induced chemotaxis in mouse spleen B lymphocytes 
(a–c) and T lymphocytes (d–f). (a,d) Representative data for cell trajectory. CXCL12 (100 ng/ml) was applied to 
the left side of the reservoir, and chemotaxis was observed in the absence or presence of CGP-37157 (2 μM) in 
both sides of the reservoir. (b,e) Percentage of cells which moved toward CXCL12. (c,f) Mean displacement of 
cells. N = 3–4. Data are expressed as mean ± SEM. **P < 0.01, *P < 0.05.
Figure 7. Larger contribution of NCLX on cytosolic Ca2+ handling in spleen B lymphocytes than in 
T lymphocytes. (a) mRNA expression of major Ca2+ handling proteins expressed relative to GAPDH in 
mouse spleen B lymphocytes (white bars) and T lymphocytes (black bars). N = 3. (b,c) Effects of CGP-37157 
on responses of cytosolic Ca2+ to antigen receptor stimulation by an anti-IgM antibody (10 μg/ml) and an 
anti-CD3/CD28 antibody (10 μg/ml) in mouse spleen B lymphocytes (b) and T lymphocytes (c), respectively. 
The effect of the stimulation on cytosolic Ca2+ was evaluated as difference between basal and peak Fura 2 ratio. 
N = 3–4. Data are expressed as mean ± SEM. **P < 0.01, *P < 0.05.
www.nature.com/scientificreports/
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Discussion
NCLX was identified as a mitochondrial Na+-Ca2+ exchanger by Palty et al.19, and there is a rapidly growing liter-
ature on the physiological and pathophysiological roles of NCLX in a variety of cell types, including pancreatic β 
cells, astrocytes, cardiomyocytes, and B lymphocytes20–22,36–38.
In the present study, we showed that NCLX modulates B lymphocyte motility by regulating cytosolic Ca2+, 
and that this is a minor mechanism in T lymphocytes. Under control conditions, a chemokine induces actin 
polymerization through Rac1, possibly via increasing cytosolic Ca2+ (Figs 3 and 4, Supplementary Figs S4 and 
S5;8,26,27,29), and induces mitochondrial polarization (Fig. 5;33,34), resulting in increased motility with direction-
ality towards the chemokine. On the other hand, NCLX reduction/inhibition increases cytosolic Ca2+ even in 
the absence of chemokine (Fig. 3 and Supplementary Fig. S4), probably due to increased Ca2+ leak from the ER, 
as we reported previously20. This Ca2+ increase may activate Rac1 and facilitate actin polymerization in many 
parts of the cell, resulting in augmentation of random movement (Figs 2 and 4, Supplementary Figs S2 and S5). 
However, the chemokine may hardly be able to induce the further Rac1 activation or actin polarization needed for 
chemotaxis under this already disorganized condition (Fig. 4 and Supplementary Fig. S5). Moreover, the failure of 
mitochondrial polarization in response to a chemokine may lead to impaired chemotaxis of cells with reduced or 
inhibited NCLX, in spite of the increased random migration. The mechanism underlying the prevention of mito-
chondrial polarization by NCLX reduction/inhibition remains to be clarified. NCLX, or Ca2+ extruded by NCLX, 
is likely to be important for proper localization of mitochondria in the cell, because silencing NCLX disrupts the 
structural coordination of mitochondria and the ER, as shown in our previous study20. We propose here that 
CXCL12-CXCR4 chemotaxis signalling is associated with NCLX and/or mitochondrial polarization. However, 
since cytosolic Ca2+ affects a wide range of protein functions, other processes besides those examined in this 
study might be affected by NCLX reduction/inhibition. Further studies are needed to obtain the comprehensive 
framework of lymphocyte chemotaxis.
There is a limitation in our siRNA experiments. Since siRNA is known to have off-target effects, experiments 
with several kinds of siRNA are ideal39. The experiments were not durable in our experimental system because of 
relatively low reductions of NCLX mRNA expression with other four siRNAs tested. However, it is notable that 
similar results to NCLX siRNA experiments in A20 B lymphocytes were obtained by pharmacological inhibition 
of NCLX in A20 and spleen B lymphocytes and by NCLX knockout in DT40 B lymphocytes. This fact strongly 
suggests that the off-target effects is small, if any.
Mitochondrial polarization may have another role: to supply ATP to myosin for contraction33. Therefore, the 
impairment of chemotaxis by NCLX suppression may be caused by an inadequate supply of ATP from the mito-
chondria to myosin. An increase in cytosolic and mitochondrial Ca2+ has been reported to activate mitochondrial 
aspartate/glutamate carriers and dehydrogenases, respectively, resulting in an increased production of NADH 
and ATP in mitochondria40,41. However, the cellular ATP level, measured by luciferase assay, was comparable 
between siControl cells and siNCLX cells (the ATP content of siNCLX cells without CXCL12 was 102.4 ± 6.5% 
of siControl cells without CXCL12, N = 4). Moreover, CXCL12 did not change the ATP level in either siCon-
trol cells or siNCLX cells (in siControl cells and siNCLX cells, the ATP content in the presence of CXCL12 was 
100.7 ± 6.5% and 105.0 ± 4.2% of that in the absence of CXCL12, respectively, N = 4). These data suggest that the 
impairment of chemotaxis by NCLX reduction/inhibition was not due to impaired ATP supply.
As far as we know, this is the first report which demonstrates the involvement of a mitochondrial Ca2+ carrier 
in the regulation of B lymphocyte chemotaxis. Recent findings suggest that the mitochondrial Ca2+ uniporter 
MCU and its accessory protein MICU play roles in the motility of human endothelial cells and zebrafish blas-
tomeres, respectively17,18. However, in the present study, the contribution of MCU to the chemotaxis of A20 
lymphocytes was small (Fig. 1). Moreover, the mRNA expression levels of MCU in mouse spleen B and T lym-
phocytes were extremely low (6.4 × 10−5 ± 1.5 × 10−5 and 3.7 × 10−5 ± 1.5 × 10−5 in mouse spleen B and T lym-
phocytes, respectively (normalised to glyceraldehyde-3-phosphate dehydrogenase (GAPDH), N = 3) and 0.002 
in A20 B lymphocytes (N = 1)), suggesting that the contribution of MCU to chemotaxis in native lymphocytes, 
if any, is small.
The most unexpected finding was the difference in NCLX contribution to chemotaxis between B lymphocytes 
and T lymphocytes (Figs 6 and 7a). The particularly important role of NCLX in B lymphocytes may be attributable 
to the difference in Ca2+ dynamics between B and T lymphocytes, that is, the larger contribution of NCLX-mediated 
mitochondria-ER Ca2+ dynamics to cytosolic Ca2+ in B lymphocytes than in T lymphocytes (Fig. 7b,c).
It would be interesting to see if NCLX participates in immune responses, such as antibody production, in vivo. 
However, this would be rather difficult because non-specific effects of the mitochondrial Na+-Ca2+ exchange 
blocker CGP-37157 on L-type Ca2+ channels, which are important in the heart, nerve and muscle, cannot be 
excluded42, and retention of CGP-37157 in the body is extremely low43. The production of complete NCLX 
knockout mice would facilitate such studies.
Methods
Solutions and drugs. Ru360 and BAPTA-AM were purchased from Sigma-Aldrich. CGP-37157 was pur-
chased from Tocris Bioscience. The stock solution was prepared with DMSO, the final concentration of which 
was 0.01–0.1%.
Cell culture and transfection. Maintenance of murine A20 B lymphocytes and transfection with siRNA 
were performed as previously described20.
Transwell chemotaxis assay. Assays were performed using Transwells equipped with polycarbonate 
membrane filters (8-μm pore; Corning) according to the protocol by Hara-Chikuma et al.44. The membrane was 
coated with PBS containing 10 μg/ml fibronectin (Sigma-Aldrich) for 30 min, washed twice, and incubated in 
www.nature.com/scientificreports/
8Scientific RepoRts | 6:28378 | DOI: 10.1038/srep28378
RPMI 1640 containing 0.1% BSA for 30 min at 37 °C. The lower chamber was filled with RPMI 1640 + 0.1% BSA 
in the presence or absence of 100 ng/ml recombinant murine CXCL12 (PeproTech). Cells were starved for 1 hr in 
serum-free RPMI 1640 with 0.1% BSA, then applied to the upper chamber. The migrated cells were counted after 
5 hrs by flow cytometry analysis (FACSCalibur; BD Biosciences), and expressed as a percentage of the input cells. 
When pharmacological inhibitors were used, cells were pretreated with the inhibitors for 20 min at 37 °C, and the 
inhibitors were added to both chambers.
Real-time chemotaxis assay. Assays were performed with a μ-Slide Chemotaxis3D (ibidi GmbH) accord-
ing to the manufacturer’s instructions. Cells were conjugated with collagen I gel and applied to the observation 
area in the presence or absence of 100 ng/ml CXCL12 in one side of the reservoir. The chamber was placed in a 
CO2-incubator (Tokai hit) on the stage of a fluorescence microscope (ECLIPSE Ti; Nikon). Transmission images 
of cells were obtained every 2 min over 8 hrs using a digital CCD camera (ORCA-R2; Hamamatsu Photonics), 
and analyzed using a particle tracking tool of AQUACOSMOS software (Hamamatsu Photonics), a filtering tool 
of ImageJ (NIH) and a Chemotaxis and Migration tool (ibidi GmbH). Cells which moved directionally toward 
CXCL12 were evaluated by the position in the 90-degree area facing CXCL12 at the end of the experiment. The 
extent of chemotaxis was expressed as the percentage of directionally moved cells which moved over a distance 
equal to the average cell size (A20, ≥15 μm; splenocytes, ≥10 μm). When pharmacological inhibitors were used, 
they were applied to both sides of the reservoir.
Measurement of Ca2+i in single cells. Cytosolic Ca2+ was measured as described previously20. Cells which 
were stimulated with or without 100 ng/ml CXCL12 for 2 hrs were loaded with 5 μM Fura 2-AM, and transferred 
to a cover glass coated with fibronectin. The fluorescence images of the cells were recorded using an EM-CCD 
camera (ImagEM, Hamamatsu Photonics) mounted on a fluorescence microscope (ECLIPSE Ti) and analyzed 
with AQUACOSMOS software.
F-actin polymerization assay. Cells were applied to cover glasses coated with 10 μg/ml fibronectin, starved 
for 1 hr at 37 °C in serum-free RPMI 1640 with 0.1% BSA, and incubated with or without 100 ng/ml CXCL12 for 
2 hrs. After fixation with 3.7% formalin for 15 min at 37 °C, cells were permeabilised with 0.1% Triton-X/PBS for 
10 min, blocked with 1% BSA/PBS for 30 min, and stained with Alexa Fluor 488 phalloidin (Invitrogen) and DAPI 
(Dojindo). Immunofluorescence images were obtained using a confocal microscope (LSM 710; Zeiss). A high inten-
sity phalloidin signal was defined as a fluorescence intensity of more than 5000 a.i. and was expressed as % of cell area.
Analysis of mitochondrial polarization. Cells were applied to cover glasses coated with 10 μg/ml 
fibronectin, starved for 1 hr at 37 °C in serum-free RPMI 1640 with 0.1% BSA, and incubated with or without 
100 ng/ml CXCL12 for 2 hrs. Then cells were stained with 1 μM MitoTracker Orange (Invitrogen), and images 
were obtained using a confocal microscope (LSM 710; Zeiss). Mitochondria-polarized cells were defined as cells 
in which the mitochondria were located within one-half of the cell area.
Isolation of mouse spleen B and T lymphocytes. Female 6–10-wk-old Balb/c mice were purchased 
from Japan SLC. All experimental procedures were conducted in accordance with the guidelines of the Research 
Center of Kyoto University Graduate School of Medicine and Regulations for Animal Research at University of 
Fukui. Procedures were approved by the Committee on Animal Research of Kyoto University Graduate School of 
Medicine and the Faculty of Medical Sciences, University of Fukui. Single splenocytes were obtained by standard 
procedures45, and then B and T lymphocytes were isolated by negative selection using the MACS system (B cell 
isolation kit (#130–090–862) and CD4+ T cell kit (#130–095–248); Miltenyi Biotec K.K.), according to the man-
ufacturer’s instructions.
Quantitative PCR analysis. Quantitative PCR analysis was performed as described previously20,22. The 
primers are listed in Supplementary Table S1.
Statistical analysis. All data are presented as mean ± SEM of independent recordings. The number of inde-
pendent experiments and the number of cells per recording are presented as N and n, respectively. In the microscopy 
measurements, the responses from n individual cells were averaged for each recording. Then the statistical evalua-
tion was performed on averaged responses from N independent recordings. Each experiment was repeated inde-
pendently more than three times. Statistical analyses were performed by one-way ANOVA multiple comparisons 
(SigmaPlot, Systat Software Inc., San Jose, CA, USA). Post hoc and two-group comparisons were performed using 
the Student–Newman–Keuls test and the unpaired Student’s t test, respectively. P < 0.05 was considered significant.
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